Veopoz™ (pozelimab-bbfg) receives fda approval as the first treatment for children and adults with chaple disease

Chaple is an ultra-rare hereditary disease that can cause potentially life-threatening gastrointestinal and cardiovascular symptoms

REGN Ratings Summary

REGN Quant Ranking